U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668635) titled 'Cannabis Effects on Opioid Self-Administration' on June 19.
Brief Summary: The study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determine if cannabis can alter the drive/desire to take opioids.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Opioid Use Disorder
Cannabis Use
Intervention:
DRUG: Cannabis
Cannabis is administered three times daily during the active cannabis treatment period.
DRU...